BRD2 and cancer: Conversely, perturbations that may promote aberrant stem cell-like activity and impair differentiation (cancer-promoting genes) included bromodomain-containing proteins (BRD1, BRD2), histone acetyltransferases (EP300), and histone lysine methyltransferases (KMT2C, NSD1, SETD1B).